ATE262904T1 - Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin - Google Patents

Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin

Info

Publication number
ATE262904T1
ATE262904T1 AT99933484T AT99933484T ATE262904T1 AT E262904 T1 ATE262904 T1 AT E262904T1 AT 99933484 T AT99933484 T AT 99933484T AT 99933484 T AT99933484 T AT 99933484T AT E262904 T1 ATE262904 T1 AT E262904T1
Authority
AT
Austria
Prior art keywords
piperidyliden
nzo
cyclohepta
dihydro
pyridine
Prior art date
Application number
AT99933484T
Other languages
English (en)
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE262904(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE262904T1 publication Critical patent/ATE262904T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99933484T 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin ATE262904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10
PCT/US1999/012368 WO2000002560A1 (en) 1998-07-10 1999-07-08 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
ATE262904T1 true ATE262904T1 (de) 2004-04-15

Family

ID=22348307

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03023240T ATE432075T1 (de) 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5h-be zoä5,6ü-cyclo-heptaä1,2-büpyridin
AT99933484T ATE262904T1 (de) 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03023240T ATE432075T1 (de) 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5h-be zoä5,6ü-cyclo-heptaä1,2-büpyridin

Country Status (28)

Country Link
EP (3) EP2055303A3 (de)
JP (4) JP3224379B1 (de)
KR (1) KR100420641B1 (de)
CN (1) CN1145485C (de)
AR (4) AR016044A1 (de)
AT (2) ATE432075T1 (de)
AU (1) AU741201B2 (de)
BR (1) BR9910449A (de)
CA (2) CA2377178A1 (de)
CY (1) CY1109279T1 (de)
CZ (1) CZ300843B6 (de)
DE (2) DE69916042T2 (de)
DK (2) DK1380297T3 (de)
ES (2) ES2214871T3 (de)
HK (1) HK1030361A1 (de)
HU (1) HU228448B1 (de)
ID (1) ID28645A (de)
IL (1) IL139407A0 (de)
MY (1) MY116038A (de)
NO (1) NO331454B1 (de)
NZ (2) NZ507885A (de)
PE (1) PE20000761A1 (de)
PL (1) PL199390B1 (de)
PT (2) PT1380297E (de)
SK (1) SK288240B6 (de)
TW (1) TW575424B (de)
WO (1) WO2000002560A1 (de)
ZA (1) ZA200006224B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
WO2006008512A2 (en) * 2004-07-16 2006-01-26 Cipla Limited Anti-histaminic composition
CA2647605A1 (en) 2006-03-31 2007-10-11 Research Foundation Itsuu Laboratory Novel compound having heterocyclic ring
JP5409382B2 (ja) 2007-11-21 2014-02-05 大日本住友製薬株式会社 口腔内崩壊錠
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
EP2269586B1 (de) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische Zusammensetzung mit Desloratadin
EP2568970B1 (de) 2010-05-10 2018-12-05 Laboratorios Lesvi, S.L. Stabile pharmazeutische formulierungen mit einem antihistaminikum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra

Also Published As

Publication number Publication date
DE69916042T2 (de) 2004-11-11
DE69940932D1 (de) 2009-07-09
CY1109279T1 (el) 2012-05-23
CN1145485C (zh) 2004-04-14
WO2000002560A1 (en) 2000-01-20
CA2377178A1 (en) 2000-01-20
EP1380297B1 (de) 2009-05-27
HK1030361A1 (en) 2001-05-04
PT1073438E (pt) 2004-07-30
TW575424B (en) 2004-02-11
JP3224379B1 (ja) 2001-10-29
HU228448B1 (en) 2013-03-28
EP1380297A1 (de) 2004-01-14
CA2325014C (en) 2002-05-28
JP4160739B2 (ja) 2008-10-08
NZ512916A (en) 2003-03-28
AR021159A1 (es) 2002-06-12
ATE432075T1 (de) 2009-06-15
NZ507885A (en) 2001-08-31
CN1303284A (zh) 2001-07-11
AU741201B2 (en) 2001-11-22
EP2055303A2 (de) 2009-05-06
KR20010043402A (ko) 2001-05-25
EP1073438A1 (de) 2001-02-07
MY116038A (en) 2003-10-31
IL139407A0 (en) 2001-11-25
PT1380297E (pt) 2009-07-06
DK1073438T3 (da) 2004-05-10
HUP0101900A2 (hu) 2001-11-28
PE20000761A1 (es) 2000-08-31
ZA200006224B (en) 2001-11-01
NO20005485D0 (no) 2000-10-31
IL139407A (en) 2001-10-31
JP2005298524A (ja) 2005-10-27
DK1380297T3 (da) 2009-08-17
BR9910449A (pt) 2001-01-02
PL199390B1 (pl) 2008-09-30
NO331454B1 (no) 2012-01-09
AU4953199A (en) 2000-02-01
ID28645A (id) 2001-06-21
CZ20004056A3 (cs) 2001-03-14
DE69916042D1 (de) 2004-05-06
JP2002068983A (ja) 2002-03-08
AR021158A2 (es) 2002-06-12
JP2010265329A (ja) 2010-11-25
JP4621082B2 (ja) 2011-01-26
EP1073438B1 (de) 2004-03-31
JP2002520285A (ja) 2002-07-09
CZ300843B6 (cs) 2009-08-26
KR100420641B1 (ko) 2004-03-02
EP2055303A3 (de) 2009-12-16
NO20005485L (no) 2001-03-09
HUP0101900A3 (en) 2003-01-28
ES2214871T3 (es) 2004-09-16
CA2325014A1 (en) 2000-01-20
SK17112000A3 (sk) 2001-12-03
PL344045A1 (en) 2001-09-24
AR016044A1 (es) 2001-06-20
AR021157A2 (es) 2002-06-12
ES2326214T3 (es) 2009-10-05
SK288240B6 (sk) 2015-02-03

Similar Documents

Publication Publication Date Title
DE3573600D1 (en) 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzoû5,6¨cyclohepta-û1,2-b¨pyridine and its salts, processes for the production thereof and pharmaceutical compositions containing these compounds
SI1129088T1 (sl) Kristalinična oblika (R)-2(((3-metil-4-(2,2,2-trifluoroetoksi)-2-piridinil)metil)sulfinil)- 1H-benzimidazola
KR960009426B1 (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo£5,6|cyclohepta-£1,2-b|pyridines
ATE262904T1 (de) Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin
NO996547D0 (no) Polymorfer av 8-klor-6,11-dihydro-11-(4-piperidyliden)-5H- benzoe[5,6]cyklohepta[1,2-b]pyridin
ATE270294T1 (de) 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate
ATE274899T1 (de) Im mund zerfallende zusammensetzung mit mirtazapin
AU2003230758A1 (en) 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
DK1068194T3 (da) PDE IV-hæmmende pyridinderivater
DE60008073D1 (de) Furo[3,2-b]pyridine als 5-ht1f agonisten
IL133449A0 (en) Benzo (5, 6) cyclohepta (1, 2-b) pyridine derivatives as farnesyl protein transferase inhibitors
ATE363485T1 (de) Benzothieno(3,2-c)pyridine als alpha2- antagonisten
AU9683798A (en) Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo{5,6}cyclohepta {1,2-b}pyridin -11-ylidene)-1- piperidene carboxylate polymorph
ES2087026A1 (es) Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina.
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1073438

Country of ref document: EP